Fremont, CA, United States of America

Chungsoon Im

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Phycoil Biotechnology International. Inc., Phycoilbiotech Korea, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chungsoon Im. Retrieved from https://idiyas.com/inventor/chungsoon-im

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chungsoon Im: Innovator in Biomaterials

Introduction

Chungsoon Im is a notable inventor based in Fremont, CA, who has made significant contributions to the field of biomaterials. His work focuses on the genetic engineering of microorganisms for the production of valuable compounds.

Latest Patents

Chungsoon Im holds a patent for a genetically engineered Thraustochytrid strain designed for the production of biomaterials, including long-chain polyunsaturated fatty acids. This innovation has the potential to impact various industries, particularly in health and nutrition.

Career Highlights

Throughout his career, Chungsoon has worked with Phycoil Biotechnology International, Inc. and Phycoilbiotech Korea, Inc. These experiences have allowed him to develop his expertise in biotechnology and biomaterials.

Collaborations

Chungsoon has collaborated with Riyaz Bhat, further enhancing his research and development efforts in the field.

Conclusion

Chungsoon Im's innovative work in genetic engineering and biomaterials positions him as a key figure in advancing biotechnology. His contributions are paving the way for future developments in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…